Citric Acid Promotes Immune Function by Modulating the Intestinal Barrier
International Journal of Molecular Sciences · 19.01.2024 · 25 (2) · 1239
DOI: 10.3390/ijms25021239 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.01.2024. Verfasst von Pengcheng Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Joint Laboratory of Animal Pathogen Prevention and Control of Fujian-Nepal, College of Animal Sciences, Fujian Agriculture and Forestry University, F…. Hauptthemen laut MEDLINE: Influenza, Human, Influenza A Virus, H9N2 Subtype. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fujian Province University Students Innovation Training Project, Fujian Agriculture and Forestry University Science and Technology Innovation Fund.
Abstract (Originalsprache)
Amidst increasing concern about antibiotic resistance resulting from the overuse of antibiotics, there is a growing interest in exploring alternative agents. One such agent is citric acid, an organic compound commonly used for various applications. Our research findings indicate that the inclusion of citric acid can have several beneficial effects on the tight junctions found in the mouse intestine. Firstly, the study suggests that citric acid may contribute to weight gain by stimulating the growth of intestinal epithelial cells (IE-6). Citric acid enhances the small intestinal villus–crypt ratio in mice, thereby promoting intestinal structural morphology. Additionally, citric acid has been found to increase the population of beneficial intestinal microorganisms, including Bifidobacterium and Lactobacillus. It also promotes the expression of important protein genes such as occludin, ZO-1, and claudin-1, which play crucial roles in maintaining the integrity of the tight junction barrier in the intestines. Furthermore, in infected IEC-6 cells with H9N2 avian influenza virus, citric acid augmented the expression of genes closely associated with the influenza virus infection. Moreover, it reduces the inflammatory response caused by the viral infection and thwarted influenza virus replication. These findings suggest that citric acid fortifies the intestinal tight junction barrier, inhibits the replication of influenza viruses targeting the intestinal tract, and boosts intestinal immune function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Joint Laboratory of Animal Pathogen Prevention and Control of Fujian-Nepal, College of Animal Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
- Key Laboratory of Fujian-Taiwan Animal Pathogen Biology, College of Animal Sciences, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
ORCID-Profile: Shihong Yan, Ji-Long Chen, Song Wang
Förderung
- National Natural Science Foundation of China
- Fujian Province University Students Innovation Training Project
- Fujian Agriculture and Forestry University Science and Technology Innovation Fund
Zitieren
APA
Hu, P., Yuan, M., Guo, B., Lin, J., Yan, S., Huang, H., Chen, J. L., Wang, S., & Ma, Y. (2024). Citric Acid Promotes Immune Function by Modulating the Intestinal Barrier. International Journal of Molecular Sciences, 25(2), 1239. https://doi.org/10.3390/ijms25021239
Vancouver
Hu P, Yuan M, Guo B, Lin J, Yan S, Huang H, et al. Citric Acid Promotes Immune Function by Modulating the Intestinal Barrier. International Journal of Molecular Sciences. 2024;25(2):1239. doi:10.3390/ijms25021239
BibTeX
@article{Hu2024,
author = {Hu, Pengcheng and Yuan, Meng and Guo, Bolun and Lin, Jiaqi and Yan, Shihong and Huang, Huiqing and Chen, Ji-Long and Wang, Song and Ma, Yanmei},
title = {Citric Acid Promotes Immune Function by Modulating the Intestinal Barrier},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {2},
pages = {1239},
doi = {10.3390/ijms25021239}
}
EUVIMED